HC Surgical Specialist profits up 38% to $1.21m in Q1

New acquisitions from the previous financial year brought growth.

SGX-listed HC Surgical Specialists' profits soared 38% to $1.21m in Q1 FY2019-20 ending August, an announcement revealed. Revenue likewise jumped 27.9% to $4.92m over the same period.

The growth in revenue was partly attributed to contributions from new acquisitions during the previous financial year, which include the Jason Lim Endoscopy and Surgery (JLES) and the Medical Services @ Tampines, where an additional 50% equity interest was acquired in September 2018. Existing subsidiaries also recorded increases in income.

Other income increased mainly due to dividend income from investment in financial assets at fair value through profit or loss (“FVTPL”) of $253,000.

The company has expressed plans to expand in Vietnam through Heliconia's network.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia